Introduction Semaglutide, a medication initially developed for the treatment of type 2 diabetes, has emerged as a breakthrough in managing obesity and improving cardiovascular health. As a member of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone in the body that helps regulate blood sugar, suppress appetite, and https://elliotpjbsi.hamachiwiki.com/1105102/semaglutide_a_breakthrough_in_managing_diabetes_obesity_and_cardiovascular_health